WNTresearch
WNTresearch - WNT researchWNTresearchWNTresearchWNTresearch

WNT research

  • WntResearch
    • About WntResearch
    • Business concept and strategies
    • market Potential
    • Interview with the founder
    • History
    • Scientific advisors
  • Pipeline
    • Foxy-5
      • Phase 1 study
      • Phase 2 study
    • Articles
    • metastases
    • WNT signaling
    • Partners
      • Allucent
      • Biovica
      • SAGA diagnostics
      • The Sage Group
    • Box-5
    • Patents
  • Investor
    • Financial reports
    • Warrants series 2021/2023
    • Share issues
      • Rights issue 2022
    • The Share
    • presentations
    • Financial calendar
  • NEWS
    • Press Releases
    • Subscribe
  • Corporate Governance
    • Nomination committee
    • General meetings
    • Management
    • Board
    • Articles of association
  • Contact
  • English
    • Swedish

Anders Rabbe is appointed acting CEO

WNTresearch   →  Blog Large Image   →  Uncategorized   →  Anders Rabbe is appointed acting CEO
01
Oct
Date October 1, 2020
Categories Uncategorized

Anders Rabbe is appointed acting CEO

Link

Author David

Search

Categories

  • Emission 2
  • Uncategorized 12
  • VD Brev 1

Recent Posts

  • Extraordinary General Meeting on Wednesday, March 10February 5, 2021
  • BioStock publishes interview with acting CEO!October 27, 2020
  • Anders Rabbe is appointed acting CEOOctober 1, 2020
  • BioStock publishes interview with CEO Peter MorsingSeptember 24, 2020
  • BioStock publishes summer interview with CEO Peter MorsingJuly 9, 2020

Archives

  • February 2021
  • October 2020
  • September 2020
  • July 2020
  • April 2020
  • October 2019
  • August 2019
  • April 2019
  • March 2019

A new approach to fight tumour spread!
Foxy-5 is a unique drug candidate:
Significant medical need, first-in-class, unique mode of action, excellent pharmacokinetics, strong preclinical efficacy data, favourable safety profile

QUICK LINKS

  • Phase 2 study
  • Press Releases
  • shares

Subscribe

    

Copyright © All rights reserved.